<DOC>
	<DOCNO>NCT00362648</DOCNO>
	<brief_summary>The purpose current study evaluate whether vaccine effective , well-tolerated immunogenic among infant develop country .</brief_summary>
	<brief_title>Developing World Study RotaTeq™ ( V260-015 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>Age 4 week 12 week Dose 1 Parent able understand study procedure give consent Clinical evidence active gastrointestinal disease Subjects currently expect participate study investigational product 6 week receive last dose RotaTeq™/placebo</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>